Share on (60792793069):


| Identification |
| Name | Ruxolitinib Phosphate, CAS 1092939-17-7 |
| Structure | ![]() |
| Other name | Ruxolitinib phosphate 1092939-17-7 Ruxolitinib (phosphate) (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate UNII-436LRU32H5 Ruxolitinib phosphate salt Ruxolitinib phosphate(INCB018424) |
| Key words | Pharmaceutical, drug,Antineoplastic Agents; a Janus kinase inhibitor; treatment of intermediate or high risk myelofibrosis |
| CAS NO. | 1092939-17-7 |
| Molecular Formula | C17H21N6O4P |
| Molecular Weight | 404.367 g/mol |
| Chemical and Physical Properties | |
| Appearance | White to off-white or light pink powder |
| Solubility | Highly soluble in water, and the solubility is pH dependant. |
| Quality standard | Purity 98.0%~102.0% |
| Application | |
| Drug Indication | Ruxolitinib is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea. |
| Formulations/Preparations | tablet |
| Handling and storage | |
| Safety and Hazards | The shanghai Research Institute of Chemical industry testing center identification conclusion :1 None hazard identification, 2 The substance is not subject to IATA DGR, 3 Non packing requirements. |
| Handling and storage | Keep container tightly closed in a dry and well-ventilated place. Light sensitive. |
| Sample package | Aluminium foil bag |
| Commercial package | Fiber drum |
| UN Code | Not classfied |
| HS Code | 29419090.00 |
| Shipping group | Shipment at ambient temperature for no controlled and no dangerous goods |
| Sales restriction | NO |
| Origin | China |
| Technical Support | |
| Ruxolitinib Phosphate STD Data sheet | Yes |
| Ruxolitinib Phosphate MSDS | Yes |
| Ruxolitinib Phosphate COA | Yes |
| Ruxolitinib Phosphate Transport certificate | Yes |
| Supply ability | |
| Monthly capacity | 10kg |
| GMP | None |
| Related APIs | |
Related APIS | Tofacitinib Hydroxyurea Imatinib Nilotinib Ibrotinib |
New products from manufacturers at wholesale prices